Researcher biography

Dr Victor M. Oguoma (BSc, MScPH, PhD, MBiostat) is a Senior Research Fellow at the UQ Poche Centre for Indigenous Health.

Victor joined UQ in February 2022. Before this time, he was a Senior Research Fellow at the Health Research Institute University of Canberra and Senior Research Officer at the Menzies School of Health Research Darwin (Menzies). He held an honorary appointment at the Dasman Diabetes Institute, Kuwait and currently holds an honorary appointment at the Menzies in Darwin.

Victor completed his PhD studies in cardiometabolic disease epidemiology at Charles Darwin University before taking up an academic appointment at the Menzies where he conducted research on chronic middle ear and respiratory disease in children. He also holds a Master of Biostatistics degree from Macquarie University through the prestigious Biostatistics Collaboration of Australia program, a Master of Public Health, and a Bachelor of Medical Parasitology at Nnamdi Azikiwe University. Before his relocation to Australia in 2013, Dr Oguoma held several roles in implementing strategies to control neglected tropical diseases in Nigeria, West Africa. Since 2017, he has led/contributed to the design, implementation, and analyses of large-scale randomised controlled trials (RCTs) and epidemiological studies in the Indigenous populations of Australia, sub-Saharan Africa, and diverse populations in Kuwait. He has over 10 years of experience in public health, epidemiological, and applied biostatistics research across sectors - non-governmental organisations and academia in Australia, Africa, and the Middle East.

In collaboration with other researchers, Dr Oguoma has attracted over AU$8M in competitive National Health & Medical Research Council (NHMRC), the Medical Research Future Fund (MRFF), and International-funded collaborative research grants as Chief Investigator since 2017. He has over 60 published works in peer-reviewed journals of national and international reputation. Dr Oguoma is an Associate Editor for the Australian Journal of Rural Health and BMC Public Health. He is available to supervise Ph.D. students.

Funding awarded prior to joining UQ:

  • 2021-2026 ‘Azithromycin before Birth’- Single dose azithromycin shortly before birth to reduce infection in Aboriginal mothers and babies: a randomised controlled trial. NHMRC Clinical Trials and Cohort Studies. AU$3,632,163 (CIG)
  • 2020-2025 ‘Deadly Ears at Discharge’ - A hospital-based randomised controlled trial of an additional ear and hearing assessment to inform discharge planning by a trained Aboriginal Ear Health Worker in Aboriginal children with chronic ear infection. NHMRC Clinical Trials and Cohort Studies. AU$2,212,847 (CIE)
  • 2017-2021 A randomized trial of an intensive education intervention using network of involved diabetes patients to improve glycaemic control of type 2 diabetes patients - (Delta State) Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - The International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly). USD 66,350 (CIB)
  • 2017-2021 A community-based randomised trial of lifestyle intervention using targeted shared care approach on pregnancy outcomes in Nigerian women with gestational diabetes mellitus but without diabetes mellitus - (Enugu State) Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - The International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly). USD 127,982 (CIF)